CNMD
CONMED Corporation
45.40$
-1.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -2.1% | +6.2% | +4.3% | +7.9% | +11.1% | -9.7% | +17.2% | +3.4% | +19.1% | +5.0% | +5.2% | |
| – | +0.4% | +5.3% | +2.9% | +6.9% | +10.2% | -6.6% | +10.1% | +7.1% | +19.9% | +1.0% | +13.1% | |
| – | -4.2% | +7.0% | +5.6% | +8.8% | +11.9% | -12.3% | +23.4% | +0.6% | +18.4% | +8.4% | -1.0% | |
| – | -1.2% | +17.6% | +0.2% | +30.6% | +7.8% | -11.0% | +7.6% | +8.2% | +11.6% | +3.5% | +2.7% | |
| – | +3.1% | +11.6% | +4.0% | +1.1% | +12.5% | -6.6% | +11.0% | +9.5% | +11.4% | -10.2% | +30.4% | |
| – | -4.4% | +12.1% | +3.6% | +3.6% | +12.0% | -7.0% | +10.6% | +9.4% | +10.9% | -4.1% | +9.7% | |
| – | -3.1% | -26.4% | +24.6% | +51.9% | +11.0% | -41.8% | +138.5% | -36.2% | +72.2% | +66.1% | -29.5% | |
| – | -1.3% | +154.7% | +18.5% | +13.5% | +106.8% | +3.2% | -19.4% | -18.5% | +37.6% | -6.2% | -16.7% | |
| – | -3.3% | -57.1% | +48.3% | +76.3% | -38.4% | -94.9% | +4,460.5% | -196.9% | – | +101.7% | -56.4% | |
| – | +1.1% | -67.8% | -667.9% | – | -73.4% | -403.8% | – | -8.0% | +68.4% | +87.0% | -21.4% | |
| – | -5.3% | -51.9% | +278.4% | -26.4% | -29.9% | -66.7% | +557.2% | -228.8% | – | +105.4% | -64.5% | |
| – | -3.5% | -5.3% | +17.1% | +26.2% | +9.9% | -19.1% | +51.6% | -95.7% | +2,368.3% | +41.4% | -43.2% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.